Historical record - last NADAC publication: 2/22/2017
Product Information
VENLAFAXINE HCL 37.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2564 per EA under NDC 65862040590. Its NADAC has been published 170 times since Nov 28, 2013.
Strength
37.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862040590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/22/2017
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 37.5 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2564 per EA |
|---|---|
| All-time high | $0.4135 (Jan 13, 2016) |
| All-time low | $0.2360 (Jan 18, 2017) |
| Median price | $0.3039 |
| Average price | $0.3047 |
| Largest weekly change | +26.5% (Dec 23, 2015) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 37.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2564 per EA (NDC 65862040590), effective Feb 22, 2017.
How has the price of VENLAFAXINE HCL 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has declined 15.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 37.5 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has ranged from a low of $0.2360 (Jan 18, 2017) to a high of $0.4135 (Jan 13, 2016), with a median of $0.3039 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 37.5 MG TABLET?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0795 per EA — about 69% below VENLAFAXINE HCL 37.5 MG TABLET.
Who manufactures VENLAFAXINE HCL 37.5 MG TABLET?
VENLAFAXINE HCL 37.5 MG TABLET (NDC 65862040590) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification